Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GERONIMO 19: IVIG in elderly COVID-19 patients with severe acute respiratory failure
2020-001768-27Phase 2Completed
- Sponsor
- Centre Hospitalier de Versailles
- Start
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of immune globulin in coronavirus disease 2019 (COVID-19) and acute respiratory distress syndrome (ARDS) (2 arms), sponsored by Centre Hospitalier de Versailles. Primary endpoint: Mortality. Started Apr 2020; status: completed.
02
Drugs
immune globulin
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on 2020-001768-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001768-27.